erlotinib hydrochloride has been researched along with acitretin in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (acitretin) | Trials (acitretin) | Recent Studies (post-2010) (acitretin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,328 | 95 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirinos, RE; Falo, LD; Geskin, LJ; Pomerantz, RG | 1 |
1 other study(ies) available for erlotinib hydrochloride and acitretin
| Article | Year |
|---|---|
Acitretin for treatment of EGFR inhibitor-induced cutaneous toxic effects.
Topics: Acitretin; Administration, Oral; Diagnosis, Differential; Drug Administration Schedule; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Keratolytic Agents; Middle Aged; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2008 |